View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.
Learn about First Coast’s online and instructor-led training opportunities; get involved with the Provider Outreach and Education Advisory Group (POE-AG); and find links to the educational resources available on the Centers for Medicare